University of Houston: Discovery of Key Target for Precision Pharmacology Makes Ideal Candidate to Treat Heart Failure
May 09, 2024
May 09, 2024
HOUSTON, Texas, May 9 (TNSres) -- The University of Houston issued the following news:
* * *
Therapeutic Targeting of AKAP12 to Improve Cardiac Function in Patients with Cardiac Dysfunction
* * *
By Laurie Fickman
Researchers at the University of Houston College of Pharmacy have discovered that when there's a higher amount of a protein called AKAP12 inside the heart, it speeds up the work of an enzyme called PDE8A and can accelerat . . .
* * *
Therapeutic Targeting of AKAP12 to Improve Cardiac Function in Patients with Cardiac Dysfunction
* * *
By Laurie Fickman
Researchers at the University of Houston College of Pharmacy have discovered that when there's a higher amount of a protein called AKAP12 inside the heart, it speeds up the work of an enzyme called PDE8A and can accelerat . . .